Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

2.6K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel hydroxytyrosol esters as potential anti-amyloid and neuroprotective agents for Alzheimer's disease.

RSC medicinal chemistry·2026
Same author

Biomarker-targeted functionalized magnetic nanoparticles: synthesis and aptamer conjugation optimization toward Alzheimer's disease biosensing.

Nanoscale advances·2026
Same author

<sup>177</sup>Lu-Labeled Magnetic Nano-Formulations: Synthesis, Radio- and Physico-Chemical Characterization, Biological Applications, Current Challenges, and Future Perspectives.

Molecules (Basel, Switzerland)·2025
Same author

Redox-Active Quinazolinone Thioamide Ag(I) Complexes with Potent Antibacterial Activity: Mechanistic Insights and Hydrogel-Enhanced Efficacy.

Molecules (Basel, Switzerland)·2025
Same author

Cobalt(II) Complexes of 4'-Bromo-Fenamic Acid: Antioxidant Properties, Antibacterial Activity, and Interaction with DNA and Albumins.

International journal of molecular sciences·2025
Same author

Structural Speciation of Hybrid Ti(IV)-Chrysin Systems-Biological Profiling and Antibacterial, Anti-Inflammatory, and Tissue-Specific Anticancer Activity.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Dec 28, 2025

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

12.0K

Structurally characterized gallium-chrysin complexes with anticancer potential.

Eleftherios Halevas1, Barbara Mavroidi2, Orestis Antonoglou3

  • 1Laboratory of Materials for Electrotechnics, Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece and Institute of Biosciences & Applications, National Centre for Scientific Research "Demokritos", 15310 Athens, Greece. lefterishalevas@gmail.com.

Dalton Transactions (Cambridge, England : 2003)
|February 18, 2020
PubMed
Summary

Researchers developed novel gallium(III) complexes with the flavonoid chrysin for cancer treatment. The Ga(iii)-chrysin-imidazole complex showed significant anticancer activity in vitro, highlighting its potential as a new chemotherapy agent.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.6K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

607

Related Experiment Videos

Last Updated: Dec 28, 2025

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles

Published on: March 18, 2015

12.0K
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.6K
Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
09:03

Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula

Published on: January 26, 2024

607

Area of Science:

  • Medicinal Chemistry
  • Inorganic Chemistry
  • Biochemistry

Background:

  • Metal-based chemotherapeutics offer anticancer efficacy but face limitations due to toxicity.
  • Natural products, particularly flavonoids, present a promising alternative for developing novel anticancer agents.
  • Flavonoids can serve as ligands to create bioactive metal complexes with enhanced therapeutic properties.

Purpose of the Study:

  • To synthesize and characterize novel gallium(III) complexes incorporating the flavonoid chrysin.
  • To investigate the anticancer potential and mechanism of action of these new metal-flavonoid complexes.
  • To explore the structure-activity relationship of Ga(iii) complexes with different ancillary ligands.

Main Methods:

  • Synthesis of three novel Ga(iii) complexes with chrysin and ancillary ligands (1,10-phenanthroline, 2,2'-bipyridine, imidazole).
  • Detailed structural and physicochemical characterization using crystallographic and spectroscopic techniques.
  • In vitro cytotoxicity evaluation against various cancer cell lines and assessment of reactive oxygen species (ROS) generation.

Main Results:

  • Successful synthesis and full characterization of three unique Ga(iii)-flavonoid complexes.
  • The complexes demonstrated significant in vitro cytotoxicity against a panel of cancer cell lines.
  • The Ga(iii)-chrysin-imidazole complex exhibited superior anticancer efficacy, with IC50 values below 1.18 μM and notable ROS generation.

Conclusions:

  • Novel Ga(iii) complexes with chrysin and ancillary ligands were successfully synthesized and characterized.
  • These complexes display promising anticancer activity and ROS-generating potential in vitro.
  • The Ga(iii)-chrysin-imidazole complex warrants further investigation as a potential lead compound for anticancer drug development.